OKYO Pharma Limited
OKYO
$2.39
-$0.04-1.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.79% | 88.79% | -- | -75.60% | -79.56% |
| Total Receivables | 225.19% | 225.19% | -- | -- | -40.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 73.25% | 73.25% | -- | -- | -24.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 138.98% | 138.98% | -- | -- | -70.41% |
|
|
|||||
| Total Current Assets | 138.98% | 138.98% | -- | -- | -70.41% |
| Net Property, Plant & Equipment | -41.18% | -41.18% | -- | -- | -52.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 138.58% | 138.58% | -- | -- | -70.38% |
|
|
|||||
| Total Accounts Payable | 28.91% | 28.91% | -- | -- | 164.76% |
| Total Accrued Expenses | 4.12% | 4.12% | -- | -- | -55.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -14.26% | -14.26% | -- | -- | 41.80% |
| Total Other Current Liabilities | -14.26% | -14.26% | -- | -- | 41.80% |
| Total Current Liabilities | 24.34% | 24.34% | -- | -- | 2.25% |
|
|
|||||
| Total Current Liabilities | 24.34% | 24.34% | -- | -- | 2.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.34% | 24.34% | -- | -- | 2.25% |
|
|
|||||
| Common Stock & APIC | 2.52% | 2.52% | -- | -- | 8.93% |
| Retained Earnings | -0.35% | -0.35% | -- | -- | -13.39% |
| Treasury Stock & Other | -42.86% | -42.86% | -- | -- | 16.44% |
| Total Common Equity | 5.61% | 5.61% | -- | -251.92% | -186.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.61% | 5.61% | -- | -251.92% | -186.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.61% | 5.61% | -- | -251.92% | -186.36% |
|
|
|||||